Acquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer.

Donavan T. Cheng, Talia N. Mitchell, Ahmet Zehir, Ronak H. Shah, Ryma Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Yu Liu, Helen H. Won, Sasinya N. Scott, A. Rose Brannon, Catherine O'Reilly, Justyna Sadowska, Jacklyn Casanova, Angela Yannes, Jaclyn F. Hechtman, Jinjuan Yao, Wei Song, Dara S. Ross, Alifya Oultache, Snjezana Dogan, Laetitia Borsu, Meera Hameed, Khedoudja Nafa, Maria E. Arcila, Marc Ladanyi, Michael F. Berger, Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology The Journal of Molecular Diagnostics. ,vol. 17, pp. 251- 264 ,(2015) , 10.1016/J.JMOLDX.2014.12.006

Marie Brevet, Shigeki Shimizu, Matthew J. Bott, Neerav Shukla, Qin Zhou, Adam B. Olshen, Valerie Rusch, Marc Ladanyi, Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy Journal of Thoracic Oncology. ,vol. 6, pp. 864- 874 ,(2011) , 10.1097/JTO.0B013E318215A07D

Ryoichi Onozato, Takayuki Kosaka, Hiroyuki Kuwano, Yoshitaka Sekido, Yasushi Yatabe, Tetsuya Mitsudomi, Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers Journal of Thoracic Oncology. ,vol. 4, pp. 5- 11 ,(2009) , 10.1097/JTO.0B013E3181913E0E

J. Bean, C. Brennan, J.-Y. Shih, G. Riely, A. Viale, L. Wang, D. Chitale, N. Motoi, J. Szoke, S. Broderick, M. Balak, W.-C. Chang, C.-J. Yu, A. Gazdar, H. Pass, V. Rusch, W. Gerald, S.-F. Huang, P.-C. Yang, V. Miller, M. Ladanyi, C.-H. Yang, W. Pao, MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 20932- 20937 ,(2007) , 10.1073/PNAS.0710370104

Monica Kong-Beltran, Somasekar Seshagiri, Jiping Zha, Wenjing Zhu, Kaumudi Bhawe, Nerissa Mendoza, Thomas Holcomb, Kanan Pujara, Jeremy Stinson, Ling Fu, Christophe Severin, Linda Rangell, Ralph Schwall, Lukas Amler, Dineli Wickramasinghe, Robert Yauch, Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer Cancer Research. ,vol. 66, pp. 283- 289 ,(2006) , 10.1158/0008-5472.CAN-05-2749

Maria E. Arcila, Khedoudja Nafa, Jamie E. Chaft, Natasha Rekhtman, Christopher Lau, Boris A. Reva, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi, EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics Molecular Cancer Therapeutics. ,vol. 12, pp. 220- 229 ,(2013) , 10.1158/1535-7163.MCT-12-0620

Paul K. Paik, Alexander Drilon, Pang-Dian Fan, Helena Yu, Natasha Rekhtman, Michelle S. Ginsberg, Laetitia Borsu, Nikolaus Schultz, Michael F. Berger, Charles M. Rudin, Marc Ladanyi, Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping Cancer Discovery. ,vol. 5, pp. 842- 849 ,(2015) , 10.1158/2159-8290.CD-14-1467

Rebecca S. Heist, Lecia V. Sequist, Darrell Borger, Justin F. Gainor, Ronald S. Arellano, Long P. Le, Dora Dias-Santagata, Jeffrey W. Clark, Jeffrey A. Engelman, Alice T. Shaw, A. John Iafrate, Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping. Journal of Thoracic Oncology. ,vol. 11, pp. 1242- 1245 ,(2016) , 10.1016/J.JTHO.2016.06.013

Laetitia Borsu, Julie Intrieri, Linta Thampi, Helena Yu, Gregory Riely, Khedoudja Nafa, Raghu Chandramohan, Marc Ladanyi, Maria E. Arcila, Clinical Application of Picodroplet Digital PCR Technology for Rapid Detection of EGFR T790M in Next-Generation Sequencing Libraries and DNA from Limited Tumor Samples The Journal of Molecular Diagnostics. ,vol. 18, pp. 903- 911 ,(2016) , 10.1016/J.JMOLDX.2016.07.004

Sai-Hong Ignatius Ou, Ramaswamy Govindan, Keith D. Eaton, Gregory A. Otterson, Martin E. Gutierrez, Alain C. Mita, Athanassios Argiris, Nicoletta M. Brega, Tiziana Usari, Weiwei Tan, Steffan N. Ho, Francisco Robert, Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. ,vol. 12, pp. 145- 151 ,(2017) , 10.1016/J.JTHO.2016.09.131